The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need
Open accessAbstract
The WHO recognizes human African trypanosomiasis, Chagas disease and the leishmaniases as neglected tropical diseases. These diseases are caused by parasitic trypanosomatids and range in severity from mild and self-curing to near invariably fatal. Public health advances have substantially decreased the effect of these diseases in recent decades but alone will not eliminate them. In this Review, we discuss why new drugs against trypanosomatids are required, approaches that are under investigation to develop new drugs and why the drug discovery pipeline remains essentially unfilled. In addition, we consider the important challenges to drug discovery strategies and the new technologies that can address them. The combination of new drugs, new technologies and public health initiatives is essential for the management, and hopefully eventual elimination, of trypanosomatid diseases from the human population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Drug Resistance in Leishmaniasis
Croft, S. L., Sundar, S., & Fairlamb, A. H. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.111-126.2006 · Cited by 1,663
Self-citationSpiroindolones, a Potent Compound Class for the Treatment of Malaria
Rottmann, M., McNamara, C., Yeung, B. K. S., Lee, M. C. S., Zou, B., Russell, B., Seitz, P., Plouffe, D. M., Dharia, N. V., Tan, J., et al. (2010) · Science · doi:10.1126/science.1193225 · Cited by 1,206
Wager, T. T., Hou, X., Verhoest, P. R., & Villalobos, A. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100008c · Cited by 1,063
Bern, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1410150 · Cited by 770
Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases
Brenk, R., Schipani, A., James, D., Krasowski, A., Gilbert, I. H., Frearson, J., & Wyatt, P. G. (2008) · ChemMedChem · doi:10.1002/cmdc.200700139 · Cited by 709
Self-citationRandomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
Molina, I., Gómez i Prat, J., Salvador, F., Treviño, B., Sulleiro, E., Serre, N., Pou, D., Roure, S., Cabezos, J., Valerio, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313122 · Cited by 604
Chagas disease in Spain, the United States and other non-endemic countries
Gascon, J., Bern, C., & Pinazo, M.-J. (2010) · Acta Tropica · doi:10.1016/j.actatropica.2009.07.019 · Cited by 601
Priotto, G., Kasparian, S., Mutombo, W., Ngouama, D., Ghorashian, S., Arnold, U., Ghabri, S., Baudin, E., Buard, V., Kazadi-Kyanza, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61117-x · Cited by 533
Innovative lead discovery strategies for tropical diseases
Nwaka, S., & Hudson, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2144 · Cited by 521
Wager, T. T., Chandrasekaran, R. Y., Hou, X., Troutman, M. D., Verhoest, P. R., Villalobos, A., & Will, Y. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100007x · Cited by 477
Alsford, S., Turner, D. J., Obado, S. O., Sanchez-Flores, A., Glover, L., Berriman, M., Hertz-Fowler, C., & Horn, D. (2011) · Genome Research · doi:10.1101/gr.115089.110 · Cited by 470
Self-citationA novel multiple-stage antimalarial agent that inhibits protein synthesis
Baragaña, B., Hallyburton, I., Lee, M. C. S., Norcross, N. R., Grimaldi, R., Otto, T. D., Proto, W. R., Blagborough, A. M., Meister, S., Wirjanata, G., et al. (2015) · Nature · doi:10.1038/nature14451 · Cited by 454
Self-citationTargeting Plasmodium PI(4)K to eliminate malaria
McNamara, C. W., Lee, M. C. S., Lim, C. S., Lim, S. H., Roland, J., Nagle, A., Simon, O., Yeung, B. K. S., Chatterjee, A. K., McCormack, S. L., et al. (2013) · Nature · doi:10.1038/nature12782 · Cited by 431
Jin, G., & Wong, S. T. C. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.11.005 · Cited by 416
Desquesnes, M., Holzmüller, P., Lai, D., Dargantes, A. P., Lun, Z., & Jittaplapong, S. (2013) · BioMed Research International · doi:10.1155/2013/194176 · Cited by 416
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
Khare, S., Nagle, A. S., Biggart, A., Lai, Y. H., Liang, F., Davis, L. C., Barnes, S. W., Mathison, C. J. N., Myburgh, E., Gao, M.-Y., et al. (2016) · Nature · doi:10.1038/nature19339 · Cited by 407
In vitro and in vivo experimental models for drug screening and development for Chagas disease
Romanha, A. J., Castro, S. L. D., Soeiro, M. D. N. C., Lannes-Vieira, J., Ribeiro, I., Talvani, A., Bourdin, B., Blum, B., Olivieri, B., Zani, C., et al. (2010) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762010000200022 · Cited by 356
Trypanosoma brucei Parasites Occupy and Functionally Adapt to the Adipose Tissue in Mice
Trindade, S., Rijo-Ferreira, F., Carvalho, T., Pinto-Neves, D., Guegan, F., Aresta-Branco, F., Bento, F., Young, S. A., Pinto, A., Van Den Abbeele, J., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.05.002 · Cited by 354
Four histone variants mark the boundaries of polycistronic transcription units in Trypanosoma brucei
Siegel, T. N., Hekstra, D. R., Kemp, L. E., Figueiredo, L. M., Lowell, J. E., Fenyo, D., Wang, X., Dewell, S., & Cross, G. A. M. (2009) · Genes & Development · doi:10.1101/gad.1790409 · Cited by 352
Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis
Nagle, A. S., Khare, S., Kumar, A. B., Supek, F., Buchynskyy, A., Mathison, C. J. N., Chennamaneni, N. K., Pendem, N., Buckner, F. S., Gelb, M. H., et al. (2014) · Chemical Reviews · doi:10.1021/cr500365f · Cited by 348
Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
Meister, S., Plouffe, D. M., Kuhen, K. L., Bonamy, G. M. C., Wu, T., Barnes, S. W., Bopp, S. E., Borboa, R., Bright, A. T., Che, J., et al. (2011) · Science · doi:10.1126/science.1211936 · Cited by 338
Torreele, E., Bourdin Trunz, B., Tweats, D., Kaiser, M., Brun, R., Mazué, G., Bray, M. A., & Pécoul, B. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000923 · Cited by 325
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
Frearson, J. A., Brand, S., McElroy, S. P., Cleghorn, L. A. T., Smid, O., Stojanovski, L., Price, H. P., Guther, M. L. S., Torrie, L. S., Robinson, D. A., et al. (2010) · Nature · doi:10.1038/nature08893 · Cited by 309
Self-citationSCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis
Jacobs, R. T., Nare, B., Wring, S. A., Orr, M. D., Chen, D., Sligar, J. M., Jenks, M. X., Noe, R. A., Bowling, T. S., Mercer, L. T., et al. (2011) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001151 · Cited by 305
Management of trypanosomiasis and leishmaniasis
Barrett, M. P., & Croft, S. L. (2012) · British Medical Bulletin · doi:10.1093/bmb/lds031 · Cited by 304
High-throughput decoding of antitrypanosomal drug efficacy and resistance
Alsford, S., Eckert, S. E., Baker, N., Glover, L., Sánchez‐Flores, A., Leung, K. F., Turner, D. J., Field, M. C., Berriman, M., & Horn, D. (2012) · Nature · doi:10.1038/nature10771 · Cited by 303
Self-citationProbing the Probes: Fitness Factors For Small Molecule Tools
Workman, P., & Collins, I. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.05.013 · Cited by 299
The skin is a significant but overlooked anatomical reservoir for vector-borne African trypanosomes
Capewell, P., Cren-Travaillé, C., Marchesi, F., Johnston, P., Clucas, C., Benson, R. A., Gorman, T.-A., Calvo-Alvarez, E., Crouzols, A., Jouvion, G., et al. (2016) · eLife · doi:10.7554/elife.17716 · Cited by 286
Discovery of Unconventional Kinetochores in Kinetoplastids
Akiyoshi, B., & Gull, K. (2014) · Cell · doi:10.1016/j.cell.2014.01.049 · Cited by 256
Diversity-oriented synthesis yields novel multistage antimalarial inhibitors
Kato, N., Comer, E., Sakata-Kato, T., Sharma, A., Sharma, M., Maetani, M., Bastien, J., Brancucci, N. M., Bittker, J. A., Corey, V., et al. (2016) · Nature · doi:10.1038/nature19804 · Cited by 255
New Horizons for Old Drugs and Drug Leads
Cragg, G. M., Grothaus, P. G., & Newman, D. J. (2014) · Journal of Natural Products · doi:10.1021/np5000796 · Cited by 246
Lewis, M. D., Fortes Francisco, A., Taylor, M. C., Burrell‐Saward, H., McLatchie, A. P., Miles, M. A., & Kelly, J. M. (2014) · Cellular Microbiology · doi:10.1111/cmi.12297 · Cited by 230
Genome-wide dissection of the quorum sensing signalling pathway in Trypanosoma brucei
Mony, B. M., MacGregor, P., Ivens, A., Rojas, F., Cowton, A., Young, J., Horn, D., & Matthews, K. (2014) · Nature · doi:10.1038/nature12864 · Cited by 214
Self-citationChagas Disease Cardiomyopathy: Immunopathology and Genetics
Cunha-Neto, E., & Chevillard, C. (2014) · Mediators of Inflammation · doi:10.1155/2014/683230 · Cited by 210
Possibilities and challenges for developing a successful vaccine for leishmaniasis
Srivastava, S., Shankar, P., Mishra, J., & Singh, S. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1553-y · Cited by 201
CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani
Zhang, W.-W., & Matlashewski, G. (2015) · mBio · doi:10.1128/mbio.00861-15 · Cited by 195
CRISPR-Cas9-Mediated Single-Gene and Gene Family Disruption in Trypanosoma cruzi
Peng, D., Kurup, S. P., Yao, P. Y., Minning, T. A., & Tarleton, R. L. (2015) · mBio · doi:10.1128/mbio.02097-14 · Cited by 193
Motility and more: the flagellum of Trypanosoma brucei
Langousis, G., & Hill, K. L. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3274 · Cited by 192
Gilbert, I. H. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400362b · Cited by 190
Self-citationJones, N. G., Thomas, E. B., Brown, E., Dickens, N. J., Hammarton, T. C., & Mottram, J. C. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003886 · Cited by 184
Fexinidazole: A Potential New Drug Candidate for Chagas Disease
Bahia, M. T., Andrade, I. M. D., Martins, T. A. F., Nascimento, Á. F. D. S. D., Diniz, L. D. F., Caldas, I. S., Talvani, A., Trunz, B. B., Torreele, E., & Ribeiro, I. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001870 · Cited by 183
DON, R., & IOSET, J.-R. (2014) · Parasitology · doi:10.1017/s003118201300142x · Cited by 180
The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis
Wyllie, S., Patterson, S., Stojanovski, L., Simeons, F. R. C., Norval, S., Kime, R., Read, K. D., & Fairlamb, A. H. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003326 · Cited by 172
Self-citationBarr, S. C., Warner, K. L., Kornreic, B. G., Piscitelli, J., Wolfe, A., Benet, L., & McKerrow, J. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.5160-5161.2005 · Cited by 170
Evasion of the Immune Response by Trypanosoma cruzi during Acute Infection
Cardoso, M. S., Reis-Cunha, J. L., & Bartholomeu, D. C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00659 · Cited by 169
Fruitful Decade for Antileishmanial Compounds from 2002 to Late 2011
Hussain, H., Al-Harrasi, A., Al-Rawahi, A., Green, I. R., & Gibbons, S. (2014) · Chemical Reviews · doi:10.1021/cr400552x · Cited by 160
Rycker, M. D., Hallyburton, I., Thomas, J. C., Campbell, L. A., Wyllie, S., Joshi, D., Cameron, S., Gilbert, I. H., Wyatt, P. G., Frearson, J. A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02398-12 · Cited by 160
Self-citationIn Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds
Canavaci, A. M. C., Bustamante, J. M., Padilla, A. M., Perez Brandan, C. M., Simpson, L. J., Xu, D., Boehlke, C. L., & Tarleton, R. L. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000740 · Cited by 159
Drug resistance in eukaryotic microorganisms
Fairlamb, A. H., Gow, N. A. R., Matthews, K. R., & Waters, A. P. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.92 · Cited by 156
Self-citationHigh-resolution cryo-electron microscopy structure of the Trypanosoma brucei ribosome
Hashem, Y., Georges, A. D., Fu, J., Buss, S. N., Jossinet, F., Jobe, A., Zhang, Q., Liao, H. Y., Grassucci, R. A., Bajaj, C., et al. (2013) · Nature · doi:10.1038/nature11872 · Cited by 154
Amastigotes of Trypanosoma cruzi sustain an infective cycle in mammalian cells.
Ley, V., Andrews, N. W., Robbins, E. S., & Nussenzweig, V. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.168.2.649 · Cited by 154
Metabolic Pathways Required for the Intracellular Survival of Leishmania
McConville, M. J., & Naderer, T. (2010) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090110-102913 · Cited by 148
Chagas disease: pushing through the pipeline
Clayton, J. (2010) · Nature · doi:10.1038/nature09224 · Cited by 146
Target assessment for antiparasitic drug discovery
Frearson, J. A., Wyatt, P. G., Gilbert, I. H., & Fairlamb, A. H. (2007) · Trends in Parasitology · doi:10.1016/j.pt.2007.08.019 · Cited by 144
Self-citationPatterson, S., Alphey, M. S., Jones, D. C., Shanks, E. J., Street, I. P., Frearson, J. A., Wyatt, P. G., Gilbert, I. H., & Fairlamb, A. H. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200312v · Cited by 143
Self-citationAdenylate Cyclases of Trypanosoma brucei Inhibit the Innate Immune Response of the Host
Salmon, D., Vanwalleghem, G. C., Morias, Y., Denoeud, J., Krumbholz, C., Lhomme, F., Bachmaier, S., Kador, M., Gossmann, J. A., Dias, F. B. S., et al. (2012) · Science · doi:10.1126/science.1222753 · Cited by 140
Development of Novel Drugs for Human African Trypanosomiasis
Brun, R., Don, R., Jacobs, R. T., Wang, M. Z., & Barrett, M. P. (2011) · Future Microbiology · doi:10.2217/fmb.11.44 · Cited by 138
Carnes, J., Anupama, A., Balmer, O., Jackson, A. P., Lewis, M. D., Brown, R. W. B., Cestari, I. D. S., Desquesnes, M., Gendrin, C., Hertz‐Fowler, C., et al. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003404 · Cited by 136
Raju, T. N. K. (2000) · The Lancet · doi:10.1016/s0140-6736(05)74775-9 · Cited by 133
Biogenesis, maintenance and dynamics of glycosomes in trypanosomatid parasites
Haanstra, J. R., González-Marcano, E. B., Gualdrón‐López, M., & Michels, P. A. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.09.015 · Cited by 131
Target Validation: Linking Target and Chemical Properties to Desired Product Profile
Wyatt, P. G., Gilbert, I. H., Read, K. D., & Fairlamb, A. H. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795429185 · Cited by 131
Self-citationMultiplication of Leishmania in human macrophages in vitro
Berman, J. D., Dwyer, D. M., & Wyler, D. J. (1979) · Infection and Immunity · doi:10.1128/iai.26.1.375-379.1979 · Cited by 125
Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana
Urbina, J. A., Concepción, J. L., Rangel, S., Visbal, G., & Lira, R. (2002) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(02)00206-2 · Cited by 124
Mathis, A., Holman, J. L., Sturk, L. M., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00192-06 · Cited by 122
First efficient CRISPR-Cas9-mediated genome editing in L eishmania parasites
Sollelis, L., Ghorbal, M., MacPherson, C. R., Martins, R. M., Kuk, N., Crobu, L., Bastien, P., Scherf, A., Lopez-Rubio, J.-J., & Sterkers, Y. (2015) · Cellular Microbiology · doi:10.1111/cmi.12456 · Cited by 120
Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors
Brand, S. L., Cleghorn, L. A. T., McElroy, S. P., Robinson, D. A., Smith, V. C., Hallyburton, I., Harrison, J. R., Norcross, N. R., Spinks, D., Bayliss, T., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201091t · Cited by 119
Self-citationDistinct donor and acceptor specificities of Trypanosoma brucei oligosaccharyltransferases
Izquierdo, L., Schulz, B. L., Rodrigues, J. A., Güther, M. L. S., Procter, J. B., Barton, G. J., Aebi, M., & Ferguson, M. A. J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.203 · Cited by 106
Self-citationAutoimmune Pathogenesis of Chagas Heart Disease
Bonney, K. M., & Engman, D. M. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.12.023 · Cited by 105
Drug Repositioning in the Treatment of Malaria and TB
Nzila, A. M., Ma, Z., & Chibale, K. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.95 · Cited by 99
Priotto, G., Pinoges, L., Fursa, I. B., Burke, B., Nicolay, N., Grillet, G., Hewison, C., & Balasegaram, M. (2008) · BMJ · doi:10.1136/bmj.39485.592674.be · Cited by 98
Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in Leishmania
Wyllie, S., Roberts, A. J., Norval, S., Patterson, S., Foth, B. J., Berriman, M., Read, K. D., & Fairlamb, A. H. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005971 · Cited by 91
Self-citationPharmacological Validation of Trypanosoma brucei Phosphodiesterases as Novel Drug Targets
de Koning, H. P., Gould, M. K., Sterk, G. J., Tenor, H., Kunz, S., Luginbuehl, E., & Seebeck, T. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir857 · Cited by 90
Chemical Validation of Trypanothione Synthetase
Torrie, L. S., Wyllie, S., Spinks, D., Oza, S. L., Thompson, S., Harrison, J. R., Gilbert, I. H., Wyatt, P. G., Fairlamb, A. H., & Frearson, J. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045336 · Cited by 85
Self-citationThe anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis
Patterson, S., Wyllie, S., Norval, S., Stojanovski, L., Simeons, F. R. C., Auer, J. L., Osuna‐Cabello, M., Read, K. D., & Fairlamb, A. H. (2016) · eLife · doi:10.7554/elife.09744 · Cited by 85
Self-citationKawahara, T., Siegel, T. N., Ingram, A. K., et al. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06346.x · Cited by 81
Shibata, S., Gillespie, J. R., Kelley, A. M., Napuli, A. J., Zhang, Z., Kovzun, K. V., Pefley, R., Lam, J. G., Zucker, F. H., A, W. C. V. V., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01796-10 · Cited by 79
Brand, S., Norcross, N. R., Thompson, S., Harrison, J. R., Smith, V. C., Robinson, D. A., Torrie, L. S., McElroy, S. P., Hallyburton, I., Norval, S., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500809c · Cited by 76
Self-citationHighly Sensitive In Vivo Imaging of Trypanosoma brucei Expressing “Red-Shifted” Luciferase
McLatchie, A. P., Burrell‐Saward, H., Myburgh, E., Lewis, M. D., Ward, T. H., Mottram, J. C., Croft, S. L., Kelly, J. M., & Taylor, M. C. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002571 · Cited by 76
Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness
Smith, T., Crossman, A. T., Brimacombe, J. S., & Ferguson, M. A. J. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600456 · Cited by 75
Self-citationProspects for Antiparasitic Drugs
Eisenthal, R., & Cornish-Bowden, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5500 · Cited by 73
Auty, H. K., Torr, S. J., Michoel, T., Jayaraman, S., & Morrison, L. J. (2015) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.34.2.2382 · Cited by 73
Beyond Tsetse – Implications for Research and Control of Human African Trypanosomiasis Epidemics
Welburn, S. C., Molyneux, D. H., & Maudlin, I. (2016) · Trends in Parasitology · doi:10.1016/j.pt.2015.11.008 · Cited by 71
Schulz, D., Mugnier, M. R., Paulsen, E.-M., Kim, H.-S., Chung, C., Tough, D. F., Rioja, I., Prinjha, R. K., Papavasiliou, F. N., & Debler, E. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002316 · Cited by 70
Myburgh, E., Coles, J. A., Ritchie, R., Kennedy, P. G. E., McLatchie, A. P., Rodgers, J., Taylor, M. C., Barrett, M. P., Brewer, J. M., & Mottram, J. C. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002384 · Cited by 68
Giroud, C., Ottonès, F., Coustou, V., Dacheux, D., Biteau, N., Miezan, B., Reet, N. V., Carrington, M., Doua, F., & Baltz, T. (2009) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000509 · Cited by 65
Networks of gene expression regulation in Trypanosoma brucei
CLAYTON, C. E. (2014) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2014.06.005 · Cited by 64
Antiparasitic Chemotherapy: From Genomes to Mechanisms
Horn, D., & Duraisingh, M. T. (2013) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135915 · Cited by 64
Self-citationMultifunctional class I transcription in Trypanosoma brucei depends on a novel protein complex
Brandenburg, J., Schimanski, B., Nogoceke, E., Nguyen, T. N., Padovan, J. C., Chait, B. T., Cross, G., & Günzl, A. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601905 · Cited by 63
Gould, M. K., Bachmaier, S., Ali, J. A. M., Alsford, S., Tagoe, D. N. A., Munday, J. C., Schnaufer, A. C., Horn, D., Boshart, M., & de Koning, H. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00508-13 · Cited by 62
Self-citationPentamidine Is Not a Permeant but a Nanomolar Inhibitor of the Trypanosoma brucei Aquaglyceroporin-2
Song, J., Baker, N., Rothert, M., Henke, B., Jeacock, L., Horn, D., & Beitz, E. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005436 · Cited by 62
Self-citationArchitecture of a Host–Parasite Interface: Complex Targeting Mechanisms Revealed Through Proteomics
Gadelha, C., Zhang, W., Chamberlain, J. W., Chait, B. T., Wickstead, B., & Field, M. C. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.047647 · Cited by 61
Self-citationTargeting Lysine Deacetylases (KDACs) in Parasites
Wang, Q., Rosa, B. A., Nare, B., Powell, K., Valente, S., Rotili, D., Mai, A., Marshall, G. R., & Mitreva, M. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004026 · Cited by 60
Manna, P. T., Kelly, S. L., & Field, M. C. (2013) · Molecular Phylogenetics and Evolution · doi:10.1016/j.ympev.2013.01.002 · Cited by 58
Self-citationDíaz-González, R., Luengo-Arratta, S. A., Seixas, J. D., Amata, E., Devine, W. G., Cordón-Obras, C., Rojas-Barros, D. I., Jiménez, E., Ortega, F., Crouch, S., et al. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003253 · Cited by 57
Metabolomic analysis of trypanosomatid protozoa
Creek, D. J., Anderson, J. J., McConville, M. J., & Barrett, M. P. (2011) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2011.10.003 · Cited by 56
Determinants of disease phenotype in trypanosomatid parasites
McCall, L., & McKerrow, J. H. (2014) · Trends in Parasitology · doi:10.1016/j.pt.2014.05.001 · Cited by 56
Strategies to optimize the brain availability of central nervous system drug candidates
Wager, T. T., Villalobos, A., Verhoest, P. R., Hou, X., & Shaffer, C. L. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.564158 · Cited by 54
Sienkiewicz, N., Ong, H. B., & Fairlamb, A. H. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07236.x · Cited by 53
Self-citationTweats, D. J., Trunz, B. B., & Torreele, E. (2012) · Mutagenesis · doi:10.1093/mutage/ges015 · Cited by 52
Proteomic Analysis of Clathrin Interactions in Trypanosomes Reveals Dynamic Evolution of Endocytosis
Adung’a, V. O., Gadelha, C., & Field, M. C. (2013) · Traffic · doi:10.1111/tra.12040 · Cited by 48
Self-citationModulation of the Surface Proteome through Multiple Ubiquitylation Pathways in African Trypanosomes
Zoltner, M., Leung, K. F., Alsford, S., Horn, D., & Field, M. C. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005236 · Cited by 47
Self-citationPredictive methods in drug repurposing: gold mine or just a bigger haystack?
Cavalla, D. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.12.009 · Cited by 46
The ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!
Tagoe, D. N. A., Kalejaiye, T. D., & de Koning, H. P. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00185 · Cited by 42
Infectious diseases in North Africa and North African immigrants to Europe
Khyatti, M., Trimbitas, R.-D., Zouheir, Y., Benani, A., Messaoudi, M. D. E., & Hemminki, K. (2014) · European Journal of Public Health · doi:10.1093/eurpub/cku109 · Cited by 42
Genomic and Proteomic Studies on the Mode of Action of Oxaboroles against the African Trypanosome
Jones, D. C., Foth, B. J., Urbaniak, M. D., Patterson, S., Ong, H. B., Berriman, M., & Fairlamb, A. H. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004299 · Cited by 42
Self-citationChoy, J. W., Bryant, C., Calvet, C. M., Doyle, P. S., Gunatilleke, S. S., Leung, S. S. F., Ang, K. K. H., Chen, S., Gut, J., Osés-Prieto, J. A., et al. (2013) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.9.3 · Cited by 41
Ma, J., Benz, C., Grimaldi, R., Stockdale, C., Wyatt, P. G., Frearson, J. A., & Hammarton, T. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.074591 · Cited by 41
Self-citationENTH and ANTH domain proteins participate in AP2-independent clathrin-mediated endocytosis
Manna, P. T., Gadelha, C., Puttick, A. E., & Field, M. C. (2015) · Journal of Cell Science · doi:10.1242/jcs.167726 · Cited by 34
Self-citationChemistry-based functional proteomics for drug target deconvolution
Wang, K., Yang, T., Wu, Q., Zhao, X., Nice, E. C., & Huang, C. (2012) · Expert Review of Proteomics · doi:10.1586/epr.12.19 · Cited by 32
Gilbert, I. H. (2013) · Parasitology · doi:10.1017/s0031182013001017 · Cited by 32
Self-citationLeishmaniosis (Leishmania infantum infection) in dogs
Gharbi, M., Mhadhbi, M., Rejeb, A., Jaouadi, K., Rouatbi, M., & Darghouth, M. A. (2015) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.34.2.2384 · Cited by 32
Genetic Validation of Aminoacyl-tRNA Synthetases as Drug Targets in Trypanosoma brucei
Kalidas, S., Cestari, I. D. S., Monnerat, S., Li, Q., Regmi, S., Hasle, N., Labaïed, M., Parsons, M., Stuart, K. D., & Phillips, M. A. (2014) · Eukaryotic Cell · doi:10.1128/ec.00017-14 · Cited by 31
Defining the targets of antiparasitic compounds
Skinner‐Adams, T. S., Sumanadasa, S. D. M., Fisher, G. M., Davis, R. A., Doolan, D. L., & Andrews, K. T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.002 · Cited by 30
Developing new drugs for the treatment of lymphoma
O’Connor, O. A. (2005) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2005.00470.x · Cited by 29
Damerow, M., Rodrigues, J. A., Wu, D., Güther, M. L. S., Mehlert, A., & Ferguson, M. A. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.555029 · Cited by 26
Self-citationBurrell‐Saward, H., Rodgers, J., Bradley, B., Croft, S. L., & Ward, T. H. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku393 · Cited by 21
The Social Life of African Trypanosomes
Imhof, S., & Roditi, I. J. (2015) · Trends in Parasitology · doi:10.1016/j.pt.2015.06.012 · Cited by 20
Cited by
Grams, R. J., Santos, W. L., Scorei, I. R., Abad-García, A., Rosenblum, C. A., Bita, A., Cerecetto, H., Viñas, C., & Soriano-Ursúa, M. A. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00663 · Cited by 377
Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery
(2023) · doi:10.1021/acsinfecdis.3c00431 · Cited by 10
Allosteric inhibition of trypanosomatid pyruvate kinases by a camelid single-domain antibody
Pinto Torres, J. E., Claes, M., Hendrickx, R., Yuan, M., Smiejkowska, N., Van Wielendaele, P., Hacisuleyman, A., De Winter, H., Muyldermans, S., Michels, P. A., et al. (2025) · eLife · doi:10.7554/elife.100066 · Cited by 2
Metadata
- Authors
- Field, M. C., Horn, D., Fairlamb, A. H., Ferguson, M. A. J., Gray, D. W., Read, K. D., De Rycker, M., Torrie, L. S., Wyatt, P. G., Wyllie, S., & Gilbert, I. H.
- Venue
- Nature Reviews Microbiology
- Published
- 2017-04
- Volume
- 15
- Issue
- 4
- Pages
- 217-231
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2589958932
- Cited by
- 421
- References
- 121
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.